论文信息 - Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial - 字舞流文

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Arthur S Slutsky | K. Thorpe | J. Villar | R. Badenes | C. Aldecoa | F. Suarez-Sipmann | C. Ferrando | J. Carbonell | M. Blasco | M. Castellà | Javier Fernández | P. Castro | J. Badia | N. Carbonell | A. Ambrós | C. Tornero | E. Maseda | Carmen Martín | M. Asensio | J. Soler | J. Sánchez-Ballesteros | J. M. Añón | G. Aguilar | J. Gómez-Herreras | R. L. Fernández | M. M. Fernandez | A. Serrano | J. Ferreres | R. Mellado-Artigas | R. Thomas | Mar Juan | C. Juandó-Prats | Gurpreet Lakhanpal | Anxela Vidal | Lorena Fernández | Domingo Martínez | J. Figueira | F. Ramasco | P. Blanco-Schweizer | J. Rico-Feijoó | M. Varela-Durán | A. Martínez-Ruiz | Pilar Díaz-Parada | G. Tamayo | Rafael del Campo | K. Wysocki | Pablo Serna-Grande | T. Muñoz | P. Jüni | C. Calvo | P. D. De Verno | Mario López | J. Trenado-Álvarez | María Hernández | J. D. De Andrés | Fernando Suárez-Sipmann | Carlos Ricard Javier María Manuel Pedro Joan Ramón Gerard Ferrando Mellado-Artigas Fernández Hernánd | Jaume Puig-Bernabeu | C. Ferrer | Iñaki Bilbao-Villasante | Kevin E Thorpe | Carlos Ferrando | M. Fernández | Gerardo Aguilar | J. Villar | Tomás Muñoz | José Ferreres | Kevin E. Thorpe | Peter Jüni

[1] S. Pastores,et al. Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019 , 2020, Critical care explorations.

[2] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[3] D. Angus. Oxygen Therapy for the Critically Ill. , 2020, The New England journal of medicine.

[4] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[5] Yazdan Yazdanpanah,et al. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists , 2020, Intensive Care Medicine.

[6] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[7] J. Baillie,et al. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.

[8] J. González-Martín,et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[9] Y. Hu,et al. On the use of corticosteroids for 2019-nCoV pneumonia , 2020, The Lancet.

[10] D. Schoenfeld,et al. Reappraisal of Ventilator-Free Days in Critical Care Research , 2019, American journal of respiratory and critical care medicine.

[11] G. Van den Berghe,et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 , 2018, Intensive Care Medicine.

[12] Shigui Yang,et al. Effect of low‐to‐moderate‐dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia , 2017, Influenza and other respiratory viruses.

[13] Arthur S Slutsky,et al. GOLDEN anniversary of the acute respiratory distress syndrome: still much work to do! , 2017, Current opinion in critical care.

[14] M. Balaan,et al. Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[15] G. Downey,et al. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance , 2013, European Respiratory Journal.

[16] D. Rennie,et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.

[17] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[18] W. Bos,et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial , 2011, The Lancet.

[19] P. Marik,et al. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. , 2009, Chest.

[20] Jesús Blanco,et al. An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. , 2007, American journal of respiratory and critical care medicine.

[21] N. Zhong,et al. Treatment of Severe Acute Respiratory Syndrome With Glucosteroids , 2006, Chest.

[22] J. Cidlowski,et al. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[23] R. Wheatland. Molecular mimicry of ACTH in SARS – implications for corticosteroid treatment and prophylaxis , 2004, Medical Hypotheses.

[24] P. Hawkey,et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. , 2003, Journal of medical microbiology.

[25] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[26] Y. Guan,et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[27] Wolzt,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[28] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[29] J. Gwaltney,et al. Low plasma levels of adrenocorticotropic hormone in patients with acute influenza. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[31] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .

[32] T L Petty,et al. Acute respiratory distress in adults. , 1967, Lancet.

[33] G. Van den Berghe,et al. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. , 2017, Critical care medicine.

[34] David Moher,et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. , 2015, Revista panamericana de salud publica = Pan American journal of public health.

[35] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[36] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[37] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..